On March 18, Beijing Bypsy Biotechnology Co., Ltd. (hereinafter referred to as "ACROBiosystems Bypsy") and Beijing JOINN PQRT Team Research Co., Ltd. (hereinafter referred to as "JOINN PQRT Team") signed a strategic cooperation agreement in Beijing. Dr. Sun Yu, vice president of product development of ACROBiosystems, Dr. Zhang Tiantian, director of product development of CMC, Mr. Sun Zhangyu, regional director, etc;Dr. Rao Chunming, Chief Scientist of JOINN PQRT Team, Pang Lin, Director of Cytotoxicity Department of JOINN PQRT Team, Zhai Yongzhao, Director of Comprehensive Business Department of JOINN PQRT Team, attended the signing ceremony.

The two parties recognize each other's value as strategic partners, and jointly decide to give full play to their respective innovative research and development capabilities and industrial resource advantages in the field of biomedical technology, realize business collaboration and achievement transformation in the related fields of biopharmaceutical quality research and inspection and testing, and establish a comprehensive strategy Cooperation relationship, integrate the entire chain of upstream and downstream resources,Support and promote the development and industrialization of innovative drugs.

Dr. Sun Yu of ACROBiosystems said, "Quality is the foundation of biological drug research and development. ACROBiosystems takes accelerating the research and development process of biopharmaceuticals as its mission, practices the core value of "starting from customers", and takes the lead in meeting customers' demand for product quality,The construction of strict quality management system as a strategic decision of our group. ACROBiosystems has always built a quality control system according to international standards, and every link from raw materials to finished products has been strictly verified to ensure that it provides stable and reliable key raw materials and testing solutions for partners.The CMC phase of biopharmaceuticals is a key part of the drug development process and runs through the entire life cycle of drug development. ACROBiosystems set up the brand of Resilient Supply, built a GMP production base in Suzhou, and provided GMP-grade products; Provided various solutions such as process residue detection, safety index detection, etc,Through full-scene verification, it ensures that the product meets the needs of drugs in CMC, clinical and commercialization stages, and provides comprehensive support and guarantee for the research and development, production and quality control of biopharmaceuticals. We highly recognize the industry value of JOINN Drug Inspection in drug quality testing technology innovation, industry standard development and professional support for biomedical research and development.This strategic cooperation between ACROBiosystems and JOINN PQRT Team, we will jointly develop new industry standards and build a resource sharing platform. I believe that the two sides will complement each other's advantages, jointly promote the development of the biomedical industry, and bring more efficient and accurate drug research and development and production solutions for the industry,Help more high-quality drugs on the market, and ultimately contribute to the cause of human health."

Dr. Rao Chunming of JOINN Drug Inspection mentioned, "We commend ACROBiosystems for its persistent pursuit of quality, innovation and customer experience. ACROBiosystems 'globalized localization' layout and resource integration capability as a platform-based Cornerstone enterprise in the biopharmaceutical industry,It can provide stable and reliable resource support for global biopharmaceutical research and development, accelerate the drug research and development process, and create greater value for partners. This cooperation will strongly promote the development of our biological drug quality research and inspection services. As a leading drug quality research and testing institution in China,Focus on the quality standard research of innovative drugs, the establishment of verification methods, the preparation and identification of standard substances, cell bank, bacteria and virus library, stock solution, finished product inspection and testing, production quality control and other related work, support and promote the research and development of innovative drugs and industrialization process. In the future, we look forward to working with ACROBiosystems,Jointly explore the establishment of new methods, new technologies and new standards, and strive to become an industry benchmark, guide the establishment and development of biopharmaceutical quality research and inspection and testing industry standards, and contribute to the progress of the entire biomedical industry."

After the strategic signing ceremony, the ACROBiosystems team visited JOINN PQRT Team base, and the two sides fully discussed the strategic cooperation issues.